Browse articles on EyeWorld.org from the Glaucoma section. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Neovascular glaucoma (NVG) is an aggressive, secondary glaucoma that develops in the setting of retinal ischemia. Specialists and residents weighed in on what to look for and strategies to manage this condition.
“The ASCRS Annual Meeting’s glaucoma programming and scientific content … shows me that while we have a long road ahead of us, the creativity, collaboration, and connectedness that exemplify ASCRS will help us light the way,” said Manjool Shah, MD. He shared what to expect in the Glaucoma section of the issue.
Optimizing ocular conditions prior to surgery is standard for any procedure, but eyes with glaucoma present extra considerations. EyeWorld spoke with two ophthalmologists to get insights on how to prepare eyes with glaucoma for different ocular procedures. They also shared a few intraoperative and postop considerations along the way.
Creating an effective treatment plan for a patient with uveitic glaucoma requires the ophthalmologist to consider and balance evolving, multiple, and sometimes competing disease processes. Several physicians discussed what to look for and how to manage and treat these patients.
The landscape of glaucoma surgery is a spectrum, ranging from selective laser trabeculoplasty to the more invasive heavy hitters still considered the gold standard for IOP lowering. In the middle are a wide range of MIGS options. Three glaucoma specialists discussed best practices for ab interno trabeculotomy, goniotomy, and canaloplasty.
A group of surgeons came together to draft and publish consensus guidelines for MicroPulse Transscleral Laser Therapy (Iridex). This therapy is used for a non-incisional laser glaucoma treatment that has been demonstrated to be safe and effective but does not have recommendations on optimal treatment protocols.
MIGS procedures have become a mainstay in the treatment of mild to moderate glaucoma, but what pressures can physicians realistically expect with these? Three surgeons spoke about this, as well as how MIGS can fit into the overall glaucoma management process and what to do if MIGS procedures don’t achieve the desired IOP.
There is a significant focus on stopping progression of optic nerve damage and subsequent vision loss in glaucoma, but what about patients who have already reached a point of vision loss? What modern visual rehabilitation technologies and services are available to them? EyeWorld spoke with three experts on this topic.
Patients with glaucoma who need cataract surgery have many lens options available, and it’s important for physicians to present the potential benefits and risks so patients can make the best decision. Two experienced ophthalmologists discussed different lens options for glaucoma patients and important factors to consider.
Glaucoma Editor Manjool Shah, MD, talks about what readers can expect in the Glaucoma section of the issue, as well as the value of ASCRS and the Annual Meeting. He also welcomes the newest members of the Glaucoma Editorial Board.